Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunction

Scandinavian Journal of Urology and Nephrology

Volumn 40, Issue 5, 2006, Pages 397-408

  Al Abany, Massoud ^a   Helgason, Ásgeir R ^a,b   Adolfsson, Jan ^a,b   Steineck, Gunnar ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Stockholm Centre of Public Health   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Prostate cancer; Test retest

Indexed keywords

AGED; ANUS SPHINCTER DISORDER; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEFECATION URGENCY; FUNCTION TEST; HUMAN; KAPPA STATISTICS; LARGE INTESTINE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RELIABILITY; SWEDEN; URINARY DYSFUNCTION; URINARY URGENCY;

AGED; AGED, 80 AND OVER; ANAL CANAL; FECAL INCONTINENCE; HUMANS; INTESTINE, LARGE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; URINARY INCONTINENCE; URINARY TRACT;

EID: 33750367799     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590600795362     Document Type: Article

References (33)

1. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-9.
2. Adolfsson J, Steineck G, Whitmore WF Jr. Recent results of management of palpable clinically localized prostate cancer. Cancer 1993;72:310-22.
3. Adolfsson J, Helgason AR, Dickman P, Steineck G. Urinary and bowel symptoms in men with and without prostate cancer: results from an observational study in the Stockholm area. Eur Urol 1998;33:11-6.
4. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 2001;166:947-52.
5. Penson DF. Quality of life following prostate cancer treatments. Curr Urol Rep 2000;1:71-7.
6. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582-92.
7. Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790-6.
8. Al-Abany M, Helgason AR, Cronqvist AK, Svensson C, Wersall P, Steineck G. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol 2002;41:532-42.
9. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994;74:2520-32.
10. Yeoh EE, Botten R, Russo A, McGowan R, Fraser R, Roos D, et al. Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys 2000;47:915-24.
11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
12. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984;2:472-83.
13. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.
14. Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer 1994;73:2791-802.
15. Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, et al. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996;77:554-62.
16. Hansen BJ, Flyger H, Brasso K, Schou J, Nordling J, Thorup AJ, et al. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995;76:451-8.
17. Bharucha AE, Locke GR III, Seide BM, Zinsmeister AR. A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther 2004;20:355-64.
18. Talley NJ, Phillips SF, Melton J III, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-4.
19. Helgason AR. Prostate cancer treatment and quality of life-a three-level epidemiological approach [Doctoral thesis]. Stockholm: Karolinska Institutet University Press; 1997.
20. Steineck G, Bergmark K, Henningsohn L, al Abany M, Dickman PW, Helgason AR. Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 2002;41:244-52.
21. Helgason AR, Arver S, Adolfsson J, Dickman P, Granath F, Steineck G. Potency': the validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability. Br J Urol 1998;81:135-41.
22. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 2002;81:443-50.
23. Helgason AR, Adolfsson J, Dickman P, Fredrikson M, Steineck G. Distress due to unwanted side-effects of prostate cancer treatment is related to impaired well-being (quality of life). Prostate Cancer Prostatic Dis 1998;1:128-33.
24. Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G. Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population-based study. Eur Urol 2001;40:151-62.
25. Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2002;62:215-25.
26. Henningsohn L, Steven K, Kallestrup EB, Steineck G. Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol 2002;168:168-74.
27. Dos Santos Silva I. Cancer epidemiology: principles and methods, 2nd ed. Lyon, France: IARC; 1999.
28. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
29. Gregoire JP, Moisan J, Labrecque M, Cusan L, Diamond P. Validation of a French adaptation of the international prostatic symptom score. Prog Urol 1996;6:240-9.
30. Lujan GM, Paez BA, Martin OE, Llanes GL, Berenguer SA. The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia. Arch Esp Urol 1997;50:847-3 (In Spanish).
31. El Din KE, Koch WF, de Wildt MJ, Kiemeney LA, Debruyne FM, De La Rosette JJ. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia. J Urol 1996;155:1959-64.
32. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
33. Nunnally J, Bernstein I. Psychometric theory, 3rd ed. New York: McGraw-Hill; 1994.